Back to Search
DONALD CUTLIP, M.D.
M.D.
Interventional Cardiology Physician
NPI: 1396777827IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
78140(MA)
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
78140(MA)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
UNIVERSITY OF SOUTH FLORIDA COLLEGE OF MEDICINE
Class of 1979
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Thrombotic complications associated with early and late nonadherence to dual antiplatelet therapy.
PMID 25703885·JACC Cardiovasc Interv·2015
4-observational
Clinical end points in coronary stent trials: a case for standardized definitions.
PMID 17470709·Circulation·2007
8-other
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes.
PMID 16092153·Circulation·2005
8-other
Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials.
PMID 15337693·Circulation·2004
8-other
Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with acute myocardial infarction.
PMID 14556878·Am J Cardiol·2003
3-trial
Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.
PMID 12505217·J Am Coll Cardiol·2002
4-observational
Claudication: exercise vs endoluminal revascularization (CLEVER) study update.
PMID 19660897·J Vasc Surg·2009
4-observational
Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.
PMID 19389558·J Am Coll Cardiol·2009
4-observational
Clinical endpoints in transcatheter aortic valve implantation: a call to ARC for standardised definitions.
PMID 19577979·EuroIntervention·2009
8-other
In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
PMID 19463396·JACC Cardiovasc Interv·2009
4-observational
In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study.
PMID 19608137·JACC Cardiovasc Imaging·2009
3-trial
Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
PMID 19180665·Catheter Cardiovasc Interv·2009
4-observational
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
PMID 19171853·Circulation·2009
4-observational
Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors.
PMID 19426981·Atherosclerosis·2009
8-other
Benefits of pharmacological facilitation with glycoprotein IIb-IIIa inhibitors in diabetic patients undergoing primary angioplasty for STEMI. A subanalysis of the EGYPT cooperation.
PMID 19030969·J Thromb Thrombolysis·2009
1-meta
Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting.
PMID 19539252·JACC Cardiovasc Interv·2009
4-observational
A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.
PMID 19463308·JACC Cardiovasc Interv·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- BETH ISRAEL DEACONESS MED CTR, 330 BROOKLINE AVE., ES-217
BOSTON, MA 02215 - Phone
- (617) 667-7455
Quick Facts
- NPI
- 1396777827
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 47
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile